Healios K.K. (4593.T)
JPY 181.0
(1.69%)
JPY 181.0
(1.69%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 108 Million JPY | -394.44% |
| 2022 | 90 Million JPY | 119.51% |
| 2021 | 41 Million JPY | 51.85% |
| 2020 | 27 Million JPY | 35.0% |
| 2019 | 20 Million JPY | 125.64% |
| 2018 | -78 Million JPY | -420.37% |
| 2017 | 24.34 Million JPY | -64.45% |
| 2016 | 68.49 Million JPY | -22.84% |
| 2015 | 88.77 Million JPY | -61.53% |
| 2014 | 230.76 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 358 Million JPY | 782.54% |
| 2024 Q1 | -63 Million JPY | -178.75% |
| 2023 Q4 | 80 Million JPY | 214.29% |
| 2023 FY | -265 Million JPY | -394.44% |
| 2023 Q2 | 87 Million JPY | 1142.86% |
| 2023 Q1 | 7 Million JPY | -88.33% |
| 2023 Q3 | -70 Million JPY | -180.46% |
| 2022 Q1 | 11 Million JPY | 0.0% |
| 2022 Q4 | 60 Million JPY | 650.0% |
| 2022 FY | 90 Million JPY | 119.51% |
| 2022 Q3 | 8 Million JPY | -27.27% |
| 2022 Q2 | 11 Million JPY | 0.0% |
| 2021 Q3 | 11 Million JPY | 10.0% |
| 2021 FY | 41 Million JPY | 51.85% |
| 2021 Q1 | 9 Million JPY | 50.0% |
| 2021 Q2 | 10 Million JPY | 11.11% |
| 2021 Q4 | 11 Million JPY | 0.0% |
| 2020 FY | 27 Million JPY | 35.0% |
| 2020 Q4 | 6 Million JPY | -14.29% |
| 2020 Q3 | 7 Million JPY | 0.0% |
| 2020 Q2 | 7 Million JPY | 0.0% |
| 2020 Q1 | 7 Million JPY | 0.0% |
| 2019 FY | 20 Million JPY | 125.64% |
| 2019 Q2 | -34 Million JPY | 0.0% |
| 2019 Q1 | - JPY | 0.0% |
| 2019 Q3 | 7 Million JPY | 120.59% |
| 2019 Q4 | - JPY | -100.0% |
| 2018 Q4 | - JPY | 0.0% |
| 2018 FY | -78 Million JPY | -420.37% |
| 2018 Q2 | - JPY | 0.0% |
| 2018 Q1 | - JPY | 0.0% |
| 2018 Q3 | - JPY | 0.0% |
| 2017 Q1 | 18.45 Million JPY | 4.59% |
| 2017 Q4 | - JPY | 0.0% |
| 2017 Q2 | 5.89 Million JPY | -68.04% |
| 2017 Q3 | - JPY | -100.0% |
| 2017 FY | 24.34 Million JPY | -64.45% |
| 2016 Q1 | 18.25 Million JPY | -4.95% |
| 2016 FY | 68.49 Million JPY | -22.84% |
| 2016 Q4 | 17.64 Million JPY | 26.49% |
| 2016 Q3 | 13.94 Million JPY | -25.25% |
| 2016 Q2 | 18.65 Million JPY | 2.23% |
| 2015 Q4 | 19.2 Million JPY | 26.84% |
| 2015 Q1 | 17.49 Million JPY | 0.0% |
| 2015 Q2 | 36.93 Million JPY | 111.1% |
| 2015 Q3 | 15.13 Million JPY | -59.01% |
| 2015 FY | 88.77 Million JPY | -61.53% |
| 2014 FY | 230.76 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 94.259% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -34.486% |
| GNI Group Ltd. | 22.43 Billion JPY | 99.519% |
| Linical Co., Ltd. | 3.77 Billion JPY | 97.142% |
| Trans Genic Inc. | 2.24 Billion JPY | 95.198% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -9.921% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 95.649% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | 91.645% |
| AnGes, Inc. | -3.06 Billion JPY | 103.523% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 160.77% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 98.882% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | 79.122% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | 2.664% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 92.555% |
| CanBas Co., Ltd. | -984 Million JPY | 110.976% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | 72.428% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 93.479% |
| Chiome Bioscience Inc. | 398.59 Million JPY | 72.905% |
| Kidswell Bio Corporation | 1.03 Billion JPY | 89.609% |
| PeptiDream Inc. | 17.21 Billion JPY | 99.373% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -252.884% |
| Ribomic Inc. | -10.5 Million JPY | 1128.376% |
| SanBio Company Limited | -14.5 Million JPY | 844.622% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 31771.554% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 282.908% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 7242.857% |
| StemRIM | -44.34 Million JPY | 343.523% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 96.609% |
| FunPep Company Limited | -680.28 Million JPY | 115.876% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -55.957% |
| Stella Pharma Corporation | 217.29 Million JPY | 50.299% |
| TMS Co., Ltd. | -6.95 Million JPY | 1653.957% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | 65.666% |
| Cuorips Inc. | 9.63 Million JPY | -1021.379% |
| K Pharma,Inc. | 910 Million JPY | 88.132% |
| Takara Bio Inc. | 25.45 Billion JPY | 99.576% |
| ReproCELL Incorporated | 1.1 Billion JPY | 90.224% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | 90.963% |
| StemCell Institute Inc. | 1.57 Billion JPY | 93.147% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 93.52% |
| CellSeed Inc. | 107.15 Million JPY | -0.789% |